Sudeep Pharma Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2004
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '04 Mar 31, 2004
Net Income	1,387	1,332	623.21	497.99	-
Depreciation & Amortization	104.99	89.21	78.29	47.06	-
Other Amortization	0.92	0.92	0.89	-	-
Loss (Gain) From Sale of Assets	0.41	-0.02	0.84	0.03	-
Loss (Gain) From Sale of Investments	-0.09	-0.94	-0.33	-0.51	-
Provision & Write-off of Bad Debts	5.96	-3.04	61.55	3.23	-
Other Operating Activities	78	17.12	50.23	19.95	-
Change in Accounts Receivable	-406.57	-498.91	79.02	-517.42	-
Change in Inventory	-620.88	44.15	-344.62	-190.67	-
Change in Accounts Payable	105.85	122.24	79.88	117.35	-
Change in Other Net Operating Assets	-168.61	-445.99	-145.01	-3.4	-
Operating Cash Flow	487.27	656.85	483.95	-26.39	-
Operating Cash Flow Growth	-25.82%	35.73%	-	-	-
Capital Expenditures	-642.33	-499.86	-471.53	-577.54	-
Sale of Property, Plant & Equipment	3.4	0.59	0.4	0.36	-
Sale (Purchase) of Real Estate	-	-24.76	-	-	-
Investment in Securities	-150	30	-30	192.31	-
Other Investing Activities	1.37	1.22	0.97	0.72	-
Investing Cash Flow	-787.56	-492.8	-500.16	-384.15	-
Short-Term Debt Issued	296.61	9.22	33.37	384.98	-
Long-Term Debt Issued	380	10	-	205.38	-
Total Debt Issued	676.61	19.22	33.37	590.36	-
Long-Term Debt Repaid	-95.42	-108.97	-84.65	-66.44	-
Net Debt Issued (Repaid)	581.19	-89.75	-51.28	523.92	-
Other Financing Activities	-54.23	-37.6	-46.49	-18.2	-
Financing Cash Flow	526.96	-127.35	-97.77	505.72	-
Foreign Exchange Rate Adjustments	1.64	0.05	2.26	-	-
Net Cash Flow	228.31	36.75	-111.72	95.18	-
Free Cash Flow	-155.06	157	12.42	-603.93	-
Free Cash Flow Growth	-	1164.05%	-	-	-
Free Cash Flow Margin	-3.09%	3.42%	0.29%	-17.52%	-
Free Cash Flow Per Share	-1.43	1.45	0.11	-5.57	-
Cash Interest Paid	54.23	37.6	46.49	18.2	-
Cash Income Tax Paid	405.5	447.47	224.2	175.44	-
Levered Free Cash Flow	-493.92	-161.13	-168.82	-	-
Unlevered Free Cash Flow	-459.8	-137.26	-140.18	-	-
Change in Working Capital	-1,090	-778.51	-330.73	-594.14	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.